AMPHIVENA THERAPEUTICS, INC.

Profile

Company Names

AMPHIVENA THERAPEUTICS, INC.

Addresses

611 GATEWAY BLVD., SUITE 810, SOUTH SAN FRANCISCO, CA 94080

45 JUNIPER STREET, #3, SAN FRANCISCO, CA 94103

Phone Numbers

(415) 994-6455

 

Entity Type:

CORPORATION

Industry:

OTHER HEALTH CARE, BIOTECHNOLOGY

Year Incorporated:

2012

State Incorporated:

DELAWARE

Total Amount Raised:

$65,194,169.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2018-12-10 
$38,694,170.00 
$50,000,000.00 
$11,305,830.00 
Equity 
2
2017-07-17 
$7,000,000.00 
$7,000,000.00 
$0.00 
Equity 
1
2013-07-11 
$19,499,999.00 
$19,500,000.00 
$1.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
VINAY 
 
BHASKAR 
DIRECTOR
AMPHIVENA THERAPEUTICS, INC.
LUKE 
 
EVNIN 
DIRECTOR
ENTEROMEDICS INC   |  MPM BIOVENTURES V, L.P.   |  COSTIM PHARMACEUTICALS INC.   |  AMPHIVENA THERAPEUTICS, INC.   |  POTENZA THERAPEUTICS, INC.   |  VESUVIUS PHARMACEUTICALS, INC.   |  ONCORUS, INC.   |  BLADE THERAPEUTICS, INC.   |  DIGITX PARTNERS LLC   |  TRIEZA THERAPEUTICS, INC.   |  MAVERICK THERAPEUTICS INC.   |  HARPOON THERAPEUTICS, INC.   |  TWENTYEIGHT-SEVEN, INC.   |  MPM ONCOLOGY INNOVATIONS FUND LP   |  FRONTIER MEDICINES CORP   |  WEREWOLF THERAPEUTICS, INC.   |  UMOJA BIOPHARMA, INC.   |  REDONA THERAPEUTICS, INC.
FLORIAN 
 
FISCHER 
DIRECTOR
AMPHIVENA THERAPEUTICS, INC.
JEANMARIE 
 
GUENOT 
EXECUTIVE OFFICER, DIRECTOR
SKS OCULAR 1, LLC   |  AMPHIVENA THERAPEUTICS, INC.
PHIL 
 
GUTRY 
DIRECTOR
AMPHIVENA THERAPEUTICS, INC.   |  POTENZA THERAPEUTICS, INC.   |  VESUVIUS PHARMACEUTICALS, INC.   |  CERECOR INC.
ADI 
 
HOESS 
DIRECTOR
AMPHIVENA THERAPEUTICS, INC.
MARK 
 
MCDADE 
DIRECTOR
FIVE PRIME THERAPEUTICS INC   |  DERMIRA, INC.   |  PLATELET BIOGENESIS, INC.   |  AMPHIVENA THERAPEUTICS, INC.   |  ICOSAVAX, INC.   |  TALARIS THERAPEUTICS, INC.   |  WINDMIL THERAPEUTICS, INC.   |  BOULDER CARE, INC.   |  SODA HEALTH, INC.   |  DUALITAS THERAPEUTICS, INC.
ERIC 
 
MOESSINGER 
DIRECTOR
EMULATE, INC.   |  PULSE THERAPEUTICS, INC.   |  MUSE BIOTECHNOLOGY, INC.   |  SQZ BIOTECHNOLOGIES CO   |  SEROTINY, INC.   |  EUPHRATES VASCULAR, INC.   |  AMPHIVENA THERAPEUTICS, INC.   |  ICOSAVAX, INC.   |  VISBY MEDICAL, INC.   |  PARTILLION BIOSCIENCE CORP   |  DRAGON VASCULAR, INC.
FRANK 
 
MUHLENBECK 
DIRECTOR
CONFORMIS INC   |  SOLSTICE BIOLOGICS LLC   |  AMPHIVENA THERAPEUTICS, INC.   |  GENOMEDX INC.   |  DECIPHER BIOSCIENCES, INC.
CHRISTIAN 
 
RICHARD 
DIRECTOR
BIOCLIN THERAPEUTICS, INC.   |  AMPHIVENA THERAPEUTICS, INC.   |  RAINIER THERAPEUTICS, INC.   |  LEAP THERAPEUTICS, INC.   |  SEDARE BIOSCIENCES, INC.
PETER 
 
VAN VASSELAER 
EXECUTIVE OFFICER, DIRECTOR
AMPHIVENA THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2018-12-19
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2018-12-10 
2017-07-26
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-07-17 
2017-06-26
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-07-11 
2015-05-04
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-07-11 
2013-07-26
D
Link
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2013-07-11 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#